MA Robin
Impact in
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment
Papers in
-
- Liver Disease Diagnosis and Treatment 4
-
- Peroxisome Proliferator-Activated Receptors 3
- Metabolism, Diabetes, and Cancer 1
- Co-authors
- Bernard Fromenty (6 shared papers)Dominique Pessayre (5 shared papers)Laetitia Knockaert (1 shared paper)Karima Begriche (1 shared paper)Abdellah Mansouri (1 shared paper)Anissa Igoudjil (1 shared paper)P Lettéron (4 shared papers)Gérard Feldmann (2 shared papers)
In The Last Decade
MA Robin
8 papers receiving 655 citations
Peers
Comparison fields: 5 of 72
- Pharmacology 125
- Epidemiology 345
- Hepatology 74
- Endocrinology, Diabetes and Metabolism 128
- Biochemistry 51
Countries citing papers authored by MA Robin
This map shows the geographic impact of MA Robin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MA Robin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MA Robin more than expected).
Fields of papers citing papers by MA Robin
This network shows the impact of papers produced by MA Robin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MA Robin. The network helps show where MA Robin may publish in the future.
Co-authors
The 24 scholars most cited alongside MA Robin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 226 | |
| 2 | 2004 | 221 | |
| 3 | 1997 | 90 | |
| 4 | 1996 | 60 | |
| 5 | 2011 | 31 | |
| 6 | 1996 | 30 | |
| 7 | 2021 | 4 | |
| 8 | 2006 | 2 |
About MA Robin
MA Robin is a scholar working on Epidemiology, Molecular Biology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism, having authored 8 papers that have together received 664 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Nitric Oxide and Endothelin Effects (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper), Alcohol Consumption and Health Effects (1 paper), Corneal Surgery and Treatments (1 paper), Liver Disease and Transplantation (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Pharmacology (125 citations), Epidemiology (345 citations), Hepatology (74 citations), Endocrinology, Diabetes and Metabolism (128 citations) and Biochemistry (51 citations). MA Robin has collaborated with scholars based in France and Mali. Frequent co-authors include Bernard Fromenty, Dominique Pessayre, Laetitia Knockaert, Karima Begriche, Abdellah Mansouri, Anissa Igoudjil, P Lettéron, Gérard Feldmann, A. Moreau and Alain Berson. Their work appears in journals such as Gastroenterology, British Journal of Pharmacology, American Journal of Physiology-Gastrointestinal and Liver Physiology, Journal of Hepatology and Diabetes & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.